
Liminal BioSciences LMNL
Quartalsbericht 2022-Q2
hinzugefügt 10.08.2022
Liminal BioSciences Operativer Cashflow 2011-2026 | LMNL
Operativer Cashflow Jährlich Liminal BioSciences
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| -99.6 M | -75.9 M | -99.4 M | -82.5 M | -123 M | - | - | - | - | - | - |
Alle Zahlen in CAD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -75.9 M | -123 M | -96 M |
Operativer Cashflow anderer Aktien in der Pharmaeinzelhändler
| Name | Operativer Cashflow | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Amphastar Pharmaceuticals
AMPH
|
156 M | $ 21.65 | - | $ 1.01 B | ||
|
MorphoSys AG
MOR
|
-481 M | - | 2.43 % | $ 254 M | ||
|
Advaxis
ADXS
|
-29.5 M | - | -9.65 % | $ 45.9 M | ||
|
Akouos
AKUS
|
-63.7 M | - | 0.23 % | $ 488 M | ||
|
Allakos
ALLK
|
-116 M | - | - | $ 28.6 M | ||
|
AlloVir
ALVR
|
-38.4 M | - | 4.14 % | $ 49.1 M | ||
|
I-Mab
IMAB
|
-1.3 B | - | - | $ 866 M | ||
|
Aeglea BioTherapeutics
AGLE
|
-169 M | - | - | $ 1.01 B | ||
|
Ampio Pharmaceuticals
AMPE
|
-8.56 M | - | -11.43 % | $ 502 K | ||
|
Midatech Pharma plc
MTP
|
-6.01 M | - | -18.52 % | $ 27.3 M | ||
|
Applied Molecular Transport
AMTI
|
-93.9 M | - | - | $ 10.1 M | ||
|
Applied Therapeutics
APLT
|
-55.2 M | - | - | $ 8.42 M | ||
|
Aptorum Group Limited
APM
|
-1.84 M | $ 0.9 | -0.18 % | $ 6.62 M | ||
|
Biophytis SA
BPTS
|
-23.8 M | - | -13.47 % | $ 169 M | ||
|
Genfit SA
GNFT
|
99.9 M | - | 2.54 % | $ 160 B | ||
|
ACADIA Pharmaceuticals
ACAD
|
158 M | $ 22.3 | - | $ 3.7 B | ||
|
Aptinyx
APTX
|
-59.7 M | - | -39.0 % | $ 4.57 M | ||
|
Ayala Pharmaceuticals
AYLA
|
-34.5 M | - | - | $ 7.46 M | ||
|
Brainstorm Cell Therapeutics
BCLI
|
-6.98 M | - | -2.5 % | $ 5.88 M | ||
|
BioDelivery Sciences International
BDSI
|
41 M | - | -4.8 % | $ 255 M | ||
|
AIkido Pharma
AIKI
|
22.7 M | - | 1.93 % | $ 17.4 M | ||
|
Cara Therapeutics
CARA
|
-23.5 M | - | -3.03 % | $ 260 M | ||
|
CASI Pharmaceuticals
CASI
|
-26.8 M | - | - | $ 35.4 M | ||
|
Fennec Pharmaceuticals
FENC
|
-12.5 M | $ 6.85 | - | $ 196 M | ||
|
ChromaDex Corporation
CDXC
|
13.5 M | - | -0.88 % | $ 598 M | ||
|
Aeterna Zentaris
AEZS
|
-8.58 M | - | 5.93 % | $ 314 M | ||
|
Galectin Therapeutics
GALT
|
-23.9 M | $ 2.37 | - | $ 151 M | ||
|
AgeX Therapeutics
AGE
|
-18 M | - | -10.17 % | $ 12.2 K | ||
|
Aravive
ARAV
|
-65.1 M | - | -13.39 % | $ 1.45 M | ||
|
Greenwich LifeSciences
GLSI
|
-7.27 M | $ 23.99 | - | $ 312 M | ||
|
Aridis Pharmaceuticals
ARDS
|
-29.1 M | - | 17.91 % | $ 11.1 M | ||
|
BioNTech SE
BNTX
|
890 M | $ 102.06 | - | $ 27.2 B | ||
|
Checkpoint Therapeutics
CKPT
|
-31.1 M | - | - | $ 169 M | ||
|
Avenue Therapeutics
ATXI
|
-1.83 M | - | -52.27 % | $ 4.45 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-65.7 M | - | - | $ 26.5 M | ||
|
Heron Therapeutics
HRTX
|
-27.6 M | $ 1.19 | - | $ 198 M | ||
|
Aquestive Therapeutics
AQST
|
-52.4 M | $ 4.1 | - | $ 438 M | ||
|
Arcutis Biotherapeutics
ARQT
|
-5.62 M | $ 23.42 | - | $ 2.98 B | ||
|
ImmuCell Corporation
ICCC
|
2.48 M | $ 8.25 | - | $ 74.5 M | ||
|
Autolus Therapeutics plc
AUTL
|
-284 M | $ 1.42 | - | $ 378 M | ||
|
Aptose Biosciences
APTO
|
-22 M | - | -45.71 % | $ 1.2 M | ||
|
AstraZeneca PLC
AZN
|
5.96 B | - | - | $ 96.9 B | ||
|
AVROBIO
AVRO
|
-63.2 M | - | 1083.1 % | $ 745 M | ||
|
Inventiva S.A.
IVA
|
-47.6 M | $ 5.13 | - | $ 138 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-8.95 M | $ 2.92 | - | $ 4.81 M | ||
|
BeiGene, Ltd.
BGNE
|
1.13 B | - | 0.49 % | $ 251 B | ||
|
Kamada Ltd.
KMDA
|
-8.82 M | $ 8.2 | - | $ 260 M |